Francisco Ruiz-Cabello
Overview
Explore the profile of Francisco Ruiz-Cabello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molina-Alejandre M, Perea F, Calvo V, Martinez-Toledo C, Nadal E, Sierra-Rodero B, et al.
J Immunother Cancer
. 2024 Oct;
12(10).
PMID: 39428126
Background: Loss of human leukocyte antigen (HLA) class I expression and loss of heterozygosity (LOH) are common events implicated in the primary resistance of non-small cell lung cancer (NSCLC) to...
2.
Diz-de Almeida S, Cruz R, Luchessi A, Lorenzo-Salazar J, de Heredia M, Quintela I, et al.
Elife
. 2024 Oct;
13.
PMID: 39361370
The genetic basis of severe COVID-19 has been thoroughly studied, and many genetic risk factors shared between populations have been identified. However, reduced sample sizes from non-European groups have limited...
3.
Rios-Tamayo R, Sanchez M, Gomez-Rojas S, Rodriguez-Barranco M, Segura G, Redondo-Sanchez D, et al.
Diagnostics (Basel)
. 2023 Mar;
13(6).
PMID: 36980379
Despite a lack of evidence, a bone marrow aspirate differential of 500 cells is commonly used in the clinical setting. We aimed to test the performance of 200-cell counts for...
4.
Gutierrez-Bautista J, Martinez-Chamorro A, Rodriguez-Nicolas A, Rosales-Castillo A, Jimenez P, Anderson P, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35805975
The SARS-CoV-2 disease presents different phenotypes of severity. Comorbidities, age, and being overweight are well established risk factors for severe disease. However, innate immunity plays a key role in the...
5.
Navarro-Ocon A, Blaya-Canovas J, Lopez-Tejada A, Blancas I, Sanchez-Martin R, Garrido M, et al.
Pharmaceutics
. 2022 Mar;
14(3).
PMID: 35335881
Breast cancer is the most common type of malignancy and leading cause of cancer death among women worldwide. Despite the current revolutionary advances in the field of cancer immunotherapy, clinical...
6.
Gutierrez-Bautista J, Sampedro A, Gomez-Vicente E, Rodriguez-Granger J, Reguera J, Cobo F, et al.
Vaccines (Basel)
. 2022 Mar;
10(3).
PMID: 35335034
The vaccines designed against the SARS-CoV-2 coronavirus are based on the spike (S) protein. Processing of the S protein by antigen-presenting cells (APC) and its subsequent presentation to T cells...
7.
Cuadros M, Cano C, Garcia-Rodriguez S, Martin J, Poyatos-Andujar A, Ruiz-Cabello F, et al.
BMC Med Genomics
. 2022 Mar;
15(1):45.
PMID: 35246124
Background: DNA methylation (DNAm) age metrics have been widely accepted as an epigenetic biomarker for biological aging and disease. The purpose of this study is to assess whether or not...
8.
Caballano-Infantes E, Garcia-Garcia A, Lopez-Gomez C, Cueto A, Robles-Diaz M, Ortega-Alonso A, et al.
Biomedicines
. 2022 Jan;
10(1).
PMID: 35052736
Background: Non-alcoholic fatty liver disease (NAFLD) and idiosyncratic drug-induced liver injury (DILI) could share molecular mechanisms involving the immune system. We aimed to identify activation immunological biomarkers in invariant natural...
9.
Garcia Rabaneda C, Perea F, Bellido Diaz M, Morales Garcia A, Martinez Atienza M, Sousa Silva L, et al.
Clin Kidney J
. 2021 Nov;
14(11):2451.
PMID: 34754444
[This corrects the article DOI: 10.1093/ckj/sfaa261.].
10.
Garrido M, Perea F, Vilchez J, Rodriguez T, Anderson P, Garrido F, et al.
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680201
Total or partial loss of class I antigens reduce the recognition of specific tumor peptides by cytotoxic T lymphocytes favoring cancer immune escape during natural tumor evolution. These alterations can...